Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Snape

Showing results (21-30 of 169) with videos related to

Pageof 17
Sort By:
The Pediatric Infectious Disease Journal|January 13, 2018
Differences in Immunization Site Pain in Toddlers Vaccinated With Either the 10- or the 13-Valent Pneumococcal Conjugate VaccineJohannes Trück, Sarah Kelly, Sena Jawad, et al.
Vaccine|June 20, 2016
Attitudes towards antenatal vaccination, Group B streptococcus and participation in clinical trials: Insights from focus groups and interviews of parents and healthcare professionalsFiona McQuaid, Sophie Pask, Louise Locock, et al.
Vaccine|January 11, 2012
The challenge of post-implementation surveillance for novel meningococcal vaccinesMatthew D Snape, Duccio Medini, Scott A Halperin, et al.
Vaccine|April 30, 2013
Genetic material should be routinely collected in clinical vaccine trials--high consent rates can be achieved across all age groupsJohannes Trück, Daniel O'Connor, Tom C Darton, et al.
The Pediatric Infectious Disease Journal|February 11, 2005
Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccineMatthew D Snape, Dominic F Kelly, Ben Green, et al.
The Pediatric Infectious Disease Journal|April 19, 2016
The Antibody Response Following a Booster With Either a 10- or 13-valent Pneumococcal Conjugate Vaccine in Toddlers Primed With a 13-valent Pneumococcal Conjugate Vaccine in Early InfancyJohannes Trück, Sena Jawad, David Goldblatt, et al.
Lancet (London, England)|May 15, 2021
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity dataRobert H Shaw, Arabella Stuart, Melanie Greenland, et al.
Vaccine|February 28, 2016
Sex-dependent immune responses to infant vaccination: an individual participant data meta-analysis of antibody and memory B cellsMerryn Voysey, Charlotte I S Barker, Matthew D Snape, et al.
Vaccine|April 29, 2014
Exonic single nucleotide polymorphisms within TLR3 associated with infant responses to serogroup C meningococcal conjugate vaccineDaniel O'Connor, Catrin E Moore, Matthew D Snape, et al.
JAMA|March 15, 2017
Immune Responses to Novel Adenovirus Type 26 and Modified Vaccinia Virus Ankara-Vectored Ebola Vaccines at 1 YearRebecca L Winslow, Iain D Milligan, Merryn Voysey, et al.
Pageof 17

Showing results (21-30 of 169) with videos related to

Sort By:
Pageof 17
The Pediatric Infectious Disease Journal|January 13, 2018
Differences in Immunization Site Pain in Toddlers Vaccinated With Either the 10- or the 13-Valent Pneumococcal Conjugate VaccineJohannes Trück, Sarah Kelly, Sena Jawad, et al.
Vaccine|June 20, 2016
Attitudes towards antenatal vaccination, Group B streptococcus and participation in clinical trials: Insights from focus groups and interviews of parents and healthcare professionalsFiona McQuaid, Sophie Pask, Louise Locock, et al.
Vaccine|January 11, 2012
The challenge of post-implementation surveillance for novel meningococcal vaccinesMatthew D Snape, Duccio Medini, Scott A Halperin, et al.
Vaccine|April 30, 2013
Genetic material should be routinely collected in clinical vaccine trials--high consent rates can be achieved across all age groupsJohannes Trück, Daniel O'Connor, Tom C Darton, et al.
The Pediatric Infectious Disease Journal|February 11, 2005
Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccineMatthew D Snape, Dominic F Kelly, Ben Green, et al.
The Pediatric Infectious Disease Journal|April 19, 2016
The Antibody Response Following a Booster With Either a 10- or 13-valent Pneumococcal Conjugate Vaccine in Toddlers Primed With a 13-valent Pneumococcal Conjugate Vaccine in Early InfancyJohannes Trück, Sena Jawad, David Goldblatt, et al.
Lancet (London, England)|May 15, 2021
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity dataRobert H Shaw, Arabella Stuart, Melanie Greenland, et al.
Vaccine|February 28, 2016
Sex-dependent immune responses to infant vaccination: an individual participant data meta-analysis of antibody and memory B cellsMerryn Voysey, Charlotte I S Barker, Matthew D Snape, et al.
Vaccine|April 29, 2014
Exonic single nucleotide polymorphisms within TLR3 associated with infant responses to serogroup C meningococcal conjugate vaccineDaniel O'Connor, Catrin E Moore, Matthew D Snape, et al.
JAMA|March 15, 2017
Immune Responses to Novel Adenovirus Type 26 and Modified Vaccinia Virus Ankara-Vectored Ebola Vaccines at 1 YearRebecca L Winslow, Iain D Milligan, Merryn Voysey, et al.
Pageof 17